The gut microbiome plays a crucial role in cancer treatment outcomes by influencing responses to therapies like immunotherapy and chemotherapy. Research indicates that a diverse microbiome enhances immune modulation, improves treatment efficacy, and can even convert non-responders to responders through fecal microbiota transplantation. Patients should focus on maintaining gut health through a fiber-rich diet, discussing probiotic use with oncologists, and considering clinical trials exploring microbiome-related treatments. Understanding this connection can empower patients during their cancer journey.
Category: integrative-oncology
Medicinal mushrooms like Reishi, Turkey Tail, Lion’s Mane, and Cordyceps are powerful allies for immune balance, brain health, and resilience during cancer care when used in thoughtful, evidence-informed doses. This Complete Mushroom Dosing Guideline walks you through safe daily ranges, ideal timing (AM vs PM), and beginner-to-advanced stacking strategies so you can build a personalized protocol with your clinician instead of guessing from marketing claims. You’ll also get a free printable dosing protocol to track your mushrooms, side effects, and lab results, plus curated recommendations for research-aligned products for those ready to take the next step.
Unlock the secrets of natural killer cells (NK cells)—your body’s frontline assassins against cancer and viruses. Learn how NK cells spot tumors, release killer chemicals, and why boosting them naturally matters for immune health. #NaturalKillerCells #NKCells #CancerImmunity
The future of cancer treatment lies in combination. Discover the compelling science suggesting how repurposed drugs like ivermectin and mebendazole could work synergistically with standard therapies to improve outcomes and overcome treatment resistance.
Categories
Anti Cancer Breakthrough Therapies cancer research Coco the Koala Reports Courage Foundation Projects drug repurposing Drug Repurposing & Innovation Integrative Oncology Insights integrative-oncology Ivermectin MD Anderson Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Research News & Updates
Coco’s Big News: Courage Against Cancer Joins Forces with MD Anderson!
G’day mates — it’s me, Coco the Koala, and I can hardly contain my excitement! Today’s a historic moment for our Courage Against Cancer family. 🧬
We’ve just submitted our very first Sponsored Research Agreement (SRA) to MD Anderson Cancer Center — one of the world’s leading institutions in cancer research. Together, we’re launching a preclinical trial studying ivermectin and mebendazole as potential treatments against ovarian cancer.
It’s the first courageous step toward FDA-approved, non-chemotherapy cancer therapies — and I’m beaming with hope! Stay tuned as we climb this new branch of discovery, one brave leaf at a time.
Stay Courageous, mates. Healing is possible.
— Coco the Koala 🐨
Facing limited options? This guide helps patients and caregivers navigate the difficult path of considering repurposed drugs, emphasizing safety, open communication with your oncologist, and informed decision-making.
Courage Against Cancer explores how ivermectin and mebendazole — two promising repurposed drugs — may enhance the effectiveness of standard cancer treatments. Learn how our ovarian cancer preclinical study aims to uncover synergistic potential that could redefine the future of integrative oncology.
In the face of a growing cancer crisis, the urgent need for alternative treatment options has become increasingly clear. This article examines the limitations of conventional therapies like chemotherapy and radiation and why embracing non-traditional treatments, such as those involving Ivermectin and Mebendazole, is crucial for enhancing patient outcomes and quality of life. By diversifying treatment options, we can provide hope to patients and families during their most challenging times.
In a landscape dominated by hype and headlines, our foundation is dedicated to a single, clear mission: moving the conversation about repurposed drugs like ivermectin and mebendazole from anecdote to evidence through rigorous, independent science.
Courage Against Cancer announces a new preclinical research initiative studying ivermectin and mebendazole against ovarian cancer. Learn what science currently shows about these repurposed antiparasitic drugs — and why this research may change the future of cancer therapy.